Summary of Key Points Core Viewpoint - Tianyi Medical (301097) has shown a significant increase in stock price, closing at 48.4 yuan on July 25, 2025, with a rise of 4.85% [1] Financial Performance - The company reported a main revenue of 98.51 million yuan in Q1 2025, reflecting a year-on-year increase of 1.65% [5] - The net profit attributable to shareholders was 4.88 million yuan, a decrease of 9.81% year-on-year [5] - The company experienced a negative non-recurring net profit of -520,700 yuan, down 123.38% year-on-year [5] - The gross profit margin stood at 33.25% [5] Market Activity - On July 25, 2025, the net inflow of main funds was 4.05 million yuan, accounting for 2.98% of the total transaction amount [1][2] - Retail investors contributed a net inflow of 3.07 million yuan, representing 2.26% of the total transaction amount [1][2] - The stock had a turnover rate of 15.33% on the same day, with a total transaction volume of 28,100 hands and a transaction amount of 136 million yuan [1] Financing and Margin Trading - On July 25, 2025, the financing balance was 39.70 million yuan, with a net financing purchase of 1.70 million yuan [3] - There were no shares sold or repaid in the margin trading segment, indicating no activity in this area [3] Industry Comparison - Tianyi Medical's total market value is 2.853 billion yuan, significantly lower than the industry average of 11.518 billion yuan [5] - The company's net asset value is 1.194 billion yuan, compared to the industry average of 3.919 billion yuan [5] - The price-to-earnings ratio (P/E) is 146.28, which is considerably higher than the industry average of 63.28 [5] - The net profit margin of 4.95% is below the industry average of 10.86% [5]
天益医疗（301097）7月25日主力资金净买入405.01万元